Crispr Therapeutics: “Everybody likes Crispr. I find it to be very risky. I’m going to say that as long as you recognize it’s a pure spec, I’m O.K., but otherwise no.”
BP: “I’ve been very disappointed in all fossil fuels. … I’m not going to let anybody else get into that chamber of” the house of pain.
Organigram: “No. We’re not doing any cannabis. I mean until we see Canopy bottom, this group is just … I’m not letting you in it.”
Grocery Outlet: “I think it’s terrific. I like Grocery, I liked it before this quarter and I like it again.”
State Street: “No, I want to own regular banks here. I like J. P. Morgan. Hey, call me old fashion. I think [CEO Jamie Morgan’s] doing a great job.”
Revolve Group: “This stock keeps going down. … I like Revolve, I am alone though. So remember: could be more pain.”
Dish Network: “Very, very smart management. Can’t think of a reason for it to go up. … I can’t recommend it, I just can’t because I don’t like the balance sheet and there’s just too many things that have to go right.”
Marketaxess: “I like that stock very much.”
Brookfield Infrastructure: “I think that one could be peaking out, too.”
Disclosure: Cramer’s charitable trust owns shares of BP and J. P. Morgan Chase.